期刊
BIOACTIVE MATERIALS
卷 5, 期 1, 页码 92-101出版社
KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2020.01.006
关键词
Immunosuppression; Tumor microenvironment; Peptide; Nanoparticle
资金
- National Heart, Lung, and Blood Institute (NHLBI) [R00HL124279]
- NIH New Innovator Award [DP2DK121328]
- L.K. Whittier Foundation
- Ming Hsieh Institute for Research on Engineering-Medicine for Cancer
- Women in Science and Engineering Gabilan Assistant Professorship
- University of Southern California
Cancer progression is marked by the infiltration of immunosuppressive cells, such as tumor-associated macrophages (TAMs), regulatory T lymphocytes (Tregs), and myeloid-derived suppressor cells (MDSCs). These cells play a key role in abrogating the cytotoxic T lymphocyte-mediated (CTL) immune response, allowing tumor growth to proceed unabated. Furthermore, targeting these immunosuppressive cells through the use of peptides and peptide-based nanomedicine has shown promising results. Here we review the origins and functions of immunosuppressive cells in cancer progression, peptide-based systems used in their targeting, and explore future avenues of research regarding cancer immunotherapy. The success of these studies demonstrates the importance of the tumor immune microenvironment in the propagation of cancer and the potential of peptide-based nanomaterials as immunomodulatory agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据